Skip to main content
. Author manuscript; available in PMC: 2018 Nov 29.
Published in final edited form as: Clin Infect Dis. 2017 Nov 29;65(12):1977–1983. doi: 10.1093/cid/cix724

Table 3.

Effectiveness of Maternal Tdap Vaccination at Preventing Infant Pertussis, by Timing of Vaccination

Cases Controls Multivariable VEa, % (95% CI)
Total 240 % 535 %
Unvaccinated 104 43.3 177 33.1 REFERENCE
Before pregnancy 24 10.0 67 12.5 50.8 (2.1 – 75.2)
1st or 2nd trimester 5 2.1 27 5.1 64.3 (−13.8 – 88.8)
3rd trimester 17 7.1 90 16.8 77.7 (48.3 – 90.4)
After pregnancy 90 37.5 174 32.5 4.9 (−49.3 – 39.5)

Abbreviations: CI, confidence interval; VE, vaccine effectiveness

a

The following variables were included in the final model: household size >2 persons, maternal education, household member with pertussis diagnosis, and infant age (weeks).